✦ LIBER ✦

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)

✍ Scribed by Jatoi, Aminah; Ritter, Howard L.; Dueck, Amylou; Nguyen, Phuong L.; Nikcevich, Daniel A.; Luyun, Ronnie F.; Mattar, Bassam I.; Loprinzi, Charles L.

Book ID: 119320226
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 361 KB
Volume: 68
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2009.06.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line erlotinib in patients with ad

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

✍ Siow Ming Lee; Iftekhar Khan; Sunil Upadhyay; Conrad Lewanski; Stephen Falk; Ger 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 314 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer

✍ Spigel, D. R.; Burris, H. A.; Greco, F. A.; Shipley, D. L.; Friedman, E. K.; Wat 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 161 KB

A pilot study on safety and pharmacokine

A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients

✍ Aminah Jatoi; James R. Jett; Jeff Sloan; Paul Novotny; Joyce Ford; Uma Prabhakar 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 162 KB

Chemotherapy in conjunction with traditi

Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial

✍ Zhou, Zhi-yi; Xu, Ling; Li, He-gen; Tian, Jian-hui; Jiao, Li-jing; You, Sheng-fu 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 648 KB

Phase III, Randomized, Double-Blind, Pla

Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non-Small-Cell Lung Cancer

✍ Paz-Ares, L. G.; Biesma, B.; Heigener, D.; von Pawel, J.; Eisen, T.; Bennouna, J 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 163 KB

P-238 Fatigue and plasma cytokines in a

P-238 Fatigue and plasma cytokines in a randomized double-blind placebo-controlled trial of epoetin alfa in patients undergoing combined modality therapy for unresetable non-small cell lung cancer (NSCLC)

✍ DiSalvo, Wendye M.; Beggs, Virginia L.; Meyers, Louise P.; Dragnev, Konstantin H 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 363 KB